Abiomed Inc. (NASDAQ: ABMD) shares gained 0.2660% to end trading Tuesday at $313.27 per share – a net change of $0.83. Shares traded between $315.91 and $309.80 throughout the day.
About Abiomed Inc.
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.